ANI Pharmaceuticals revenue surges nearly 26%
ANI Pharmaceuticals (NASDAQ:ANIP) reported record Q2 2026 net revenue of $266.0 million, up 25.9%, while GAAP net income reached $24.7 million.
ANI Pharmaceuticals (NASDAQ:ANIP) reported record Q2 2026 net revenue of $266.0 million, up 25.9%, while GAAP net income reached $24.7 million.
Oklo (NYSE:OKLO) reported Q2 2026 revenue of $1.2 million while recording a loss of $0.28 per share, compared with an analyst loss estimate of $0.16.
Array Digital Infrastructure (NYSE:AD) reported Q2 2026 operating revenue from continuing operations of $54.1 million, up about 90%, as site rental revenue increased 95% to $53.2 million.
Construction Partners (NASDAQ:ROAD) reported fiscal Q3 2026 revenue of $999.4 million, up 28.2%, while net income increased to $59.6 million.
Take-Two Interactive Software (NASDAQ:TTWO) reported fiscal Q1 2027 GAAP net revenue of $1.53 billion, up about 2%, while net bookings fell 3% to $1.39 billion.
Atmus Filtration Technologies (NYSE:ATMU) reported record Q2 2026 net sales of $527.9 million, up 16.4%, while GAAP net income increased to $64 million.
Independent equity research firm Argus Research has upgraded SpaceX from a Hold to a Buy rating, setting a price target of US$160 per share.
Johnson Outdoors (NASDAQ:JOUT) reported fiscal Q3 2026 net sales of $189.7 million, up 5%, while operating income increased to $18.3 million from $7.3 million.
Calumet (NASDAQ:CLMT) reported a Q2 2026 net loss of $95.9 million, or $1.09 per share, compared with a $147.9 million loss a year earlier.
Nathan’s Famous (NASDAQ:NATH) reported fiscal Q1 2027 revenue of $54.1 million, up about 15%, while net income edged down to $8.8 million.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas